Incannex Healthcare Inc (IXHL)’s financial ratios: A comprehensive overview

Incannex Healthcare Inc (NASDAQ: IXHL) closed the day trading at $6.27 up 48.58% from the previous closing price of $4.22. In other words, the price has increased by $+2.05 from its previous closing price. On the day, 14191034 shares were traded. IXHL stock price reached its highest trading level at $8.47 during the session, while it also had its lowest trading level at $5.51.

Ratios:

For a better understanding of IXHL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.70 and its Current Ratio is at 6.70. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IXHL now has a Market Capitalization of 66.67M and an Enterprise Value of 52.58M.

Stock Price History:

Over the past 52 weeks, IXHL has reached a high of $12.68, while it has fallen to a 52-week low of $1.96. The 50-Day Moving Average of the stock is 4.10, while the 200-Day Moving Average is calculated to be 2.38.

Shares Statistics:

Over the past 3-months, IXHL traded about 99.48K shares per day on average, while over the past 10 days, IXHL traded about 153.59k shares per day. A total of 396.75M shares are outstanding, with a floating share count of 15.83M. Insiders hold about 0.28% of the company’s shares, while institutions hold 1.72% stake in the company. Shares short for IXHL as of Feb 15, 2024 were 97.22k with a Short Ratio of 0.98, compared to 79.95k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.61% and a Short% of Float of 0.62%.

Earnings Estimates

Current recommendations for the stock of the company come from 0 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.

Most Popular

[the_ad id="945"]